Treatment as Prevention¨

HIV incidence fell by three-quarters in Australian gay men, with strong association with treatment as prevention

HIV treatment as prevention, as measured in community-level viral suppression, was strongly associated with a large drop in the number of new HIV infections among gay and bisexual men in Australia, even before PrEP was available. This study was presented by Dr Denton Callander from the University of New South Wales yesterday at the Conference

HIV incidence fell by three-quarters in Australian gay men, with strong association with treatment as prevention Read More »

As community viremia declines, so does HIV incidence, study finds

As community viremia declined, so did the incidence of HIV infection among gay and bisexual men in a 6-year Australian study, researchers reported. The findings, presented during CROI, provide “compelling evidence that treatment as prevention can achieve population-level ‘big picture’ public health goals around reducing new cases of HIV among gay and bisexual men,” Denton

As community viremia declines, so does HIV incidence, study finds Read More »

‘EastSiders’ showcases sex and love but leaves out LGBTQ+ histories & realities

Are the days when LGBTQ+ communities stormed the gates of power in direct action long behind us? Some of us lived through the Stonewall rebellion of 1969, the Toronto bathhouse raids in 1981 and other global examples of resisting and fighting oppression. Then the HIV/AIDS crisis of the late ‘80s and ’90s hit: LGBTQ+ activists,

‘EastSiders’ showcases sex and love but leaves out LGBTQ+ histories & realities Read More »

Increased use of and confidence in antiretroviral PrEP for prevention of HIV found

More gay and bisexual men are using HIV pre-exposure prophylaxis (PrEP) with increased confidence in the benefits of HIV treatment for prevention, according to a UNSW study. Significantly more gay and bisexual men are using the antiretroviral drug PrEP to prevent HIV infection, according to the latest report from the PrEPARE Project. The national online

Increased use of and confidence in antiretroviral PrEP for prevention of HIV found Read More »

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below